JPRN-UMIN000009551已完成3 期
A Single Arm Clinical Trial in Japan for Reconstruction of Obstructive Lesions of the Superficial Femoral Artery or Proximal Popliteal Artery by Bard LifeStent - RELIABLE
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Medicon Inc.
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The subject has concomitant renal failure with a creatinine of >2.5 mg/dl or having dialysis treatment. 2. Subject has a history of bypass surgery on the study vessel. 3. Subject has a history of MI or stroke within 6 months of study procedure.
研究者
相似试验
已完成
2 期
A Phase II, Single-arm, Japanese Multicenter Trial of TH-302 in Combination with Doxorubicin in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma(EMR 200592-008)ocally advanced unresectable or metastatic STSJPRN-jRCT2080222619Merck Serono Co., Ltd.46
已完成
不适用
Japan Prospective Long Term Clinical Trial in Type 2 Diabetes Patients with Sulfonyl Urea and SitagliptiType 2 diabetesJPRN-UMIN000005415Kyoto University Graduate School of Medicine250
已完成
1 期
Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese VolunteersAcquired Bleeding DisorderCardiac Surgery Requiring Cardiopulmonary BypassHealthyNCT01153997Novo Nordisk A/S24
已完成
不适用
Japanease multi-center clinical trial to assess the inhibitory effects of branched chain amino acids on the recurrence after curative treatment of hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000002330Ministry of Health, Labour and Welfare200
已完成
4 期
Safety and Efficacy of Insulin Aspart in Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01649570Novo Nordisk A/S123